Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LY6K promotes glioblastoma tumorigenicity via CAV-1–mediated ERK1/2 signaling enhancement

11 Feb 2020

Abstract excerpt

BACKGROUND: Lymphocyte antigen 6 complex, locus K (LY6K) is a putative oncogene in various cancers. Elevated expression of LY6K is correlated with poor patient prognosis in glioblastoma (GBM). The aim of this study is to advance our understanding of the mechanism by which LY6K contributes to GBM tumor biology. METHODS: Bioinformatic data mining was used to investigate LY6K expression in relation to GBM clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Caveolin-1 and cellular processes
Share to Glioma Diagnosis and Treatment
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32055849
DOI: 10.1093/neuonc/noaa032

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LY6K promotes glioblastoma tumorigenicity via CAV-1–mediated ERK1/2 signaling enhancementPMID 32055849Read ↗

The BRAF V600E/MEK/ERK/METTL3 positive feedback loop regulates autophagy and promotes stemness and invasiveness in glioblastoma via m6A modification.Semantic proximity Read ↗

Comparative analyses identify molecular signature of MRI-classified SVZ-associated glioblastoma.Semantic proximity Read ↗

Integrated profiling identifies caveolae‐associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patientsSemantic proximity Read ↗

Identification of NEK6 as a potential biomarker for prognosis in gliomaSemantic proximity Read ↗

Elevated ETV6 Expression in Glioma Promotes an Aggressive In Vitro Phenotype Associated with Shorter Patient Survival.Semantic proximity Read ↗

Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44Semantic proximity Read ↗

STAT6 expression in glioblastoma promotes invasive growthSemantic proximity Read ↗

The NSL Chromatin-Modifying Complex Subunit KANSL2 Regulates Cancer Stem–like Properties in Glioblastoma That Contribute to TumorigenesisSemantic proximity Read ↗

Molecular and clinical features of a potential immunotherapy target ELK3 in gliomaSemantic proximity Read ↗

A Pan-Cancer Analysis of the Oncogenic Role of YKT6 in Human TumorsSemantic proximity Read ↗

Origin recognition complex 6 overexpression promotes growth of glioma cellsSemantic proximity Read ↗

HES6 gene is selectively overexpressed in glioma and represents an important transcriptional regulator of glioma proliferationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.